In ATCvet, this subgroup is named "QD05 Drugs for keratoseborrheic disorders".
D05A Antipsoriatics for topical use
::In ATCvet, this subgroup is named "QD05A Drugs for keratoseborrheic disorders, topical use".
D05AA Tars
D05AC Antracen derivatives
:D05AC01 Dithranol
:D05AC51 Dithranol, combinations
D05AD Psoralens for topical use
:D05AD01 Trioxysalen
:D05AD02 Methoxsalen
D05AX Other antipsoriatics for topical use
::In ATCvet, this subgroup is named "QD05AX Other drugs for keratoseborrheic disorders for topical use".
:D05AX01 Fumaric acid
:D05AX02 Calcipotriol
:D05AX03 Calcitriol
:D05AX04 Tacalcitol
:D05AX05 Tazarotene
:D05AX06 Roflumilast
:D05AX07 Tapinarof
:D05AX52 Calcipotriol, combinations
:D05AX55 Tazarotene and ulobetasol
D05B Antipsoriatics for systemic use
::In ATCvet, this subgroup is named "QD05B Drugs for keratoseborrheic disorders, systemic use".
D05BA Psoralens for systemic use
:D05BA01 Trioxysalen
:D05BA02 Methoxsalen
:D05BA03 Bergapten
D05BB Retinoids for treatment of psoriasis
:D05BB01 Etretinate
:D05BB02 Acitretin
D05BX Other antipsoriatics for systemic use
::In ATCvet, this subgroup is named "QD05BX Other drugs for keratoseborrheic disorders for systemic use".
:D05BX51 Fumaric acid derivatives, combinations